Skip directly to site content Skip directly to search


Centers for Disease Control and Prevention. CDC twenty four seven. Saving Lives, Protecting People
 Search

		Submit


Tuberculosis (TB)


Facebook
        Twitter
        LinkedIn
        Syndicate





TB Personal Stories – Liliana’s StoryEspañol (Spanish)										Related Pages
										Return to Main Menu
Liliana’s Story
Liliana with her husband on their wedding dayLiliana with her husband on their
wedding day
*Liliana was diagnosed with multidrug-resistant (MDR) tuberculosis (TB) in 2009. She does not recall ever being exposed to anyone with TB disease as a child or as an adult.*
In October 2008, Liliana was excitedly preparing for her wedding. Throughout that year, she had been working very hard and going to the gym so she would look her best for the wedding. But shortly before her wedding date, she started coughing.
Not wanting to be sick for her big event, she went to see a doctor and was told she had bronchitis. The doctor gave Liliana a shot of antibiotics and prescribed an inhaler. Liliana’s symptoms went away and she quickly felt better. But in December, after her honeymoon, her cough came back even worse. Deciding it was time to see a specialist, she went to a pulmonologist. He sent Liliana to get a chest x-ray, and also prescribed an inhaler and antibiotics. Liliana says, “I was better for a while and never heard back from the doctor.”
In February, her cough returned. Liliana scheduled another appointment with the same pulmonologist. “This time when the nurse came in, she was wearing a mask,” said Liliana. “I found out that the doctor had looked at my x-ray. He sent me to get blood work and sputum tests done. And that is when it all started.”
She was immediately contacted by Fort Bend County Clinical Health Services. She was told that her tests revealed she had TB disease, and she needed to go to the clinic to begin treatment.
This was not the first time Liliana had been on treatment for TB. When in high school, she underwent tuberculin skin testing, a requirement for her school’s admission, and the result was positive. Further testing had shown she did not have TB disease, which makes you sick and can be spread to others. Rather, she had latent TB infection. People with latent TB infection do not feel sick, do not have any symptoms, and are not infectious. At that time, Liliana was put on isoniazid preventive treatment for 6 months to keep the infection from becoming TB disease. She thought nothing further about TB for years. However, this time her experience was very different.
Because TB disease of the lungs is infectious until adequately treated, she learned that she would have to leave work for a few weeks. “I couldn’t just ‘leave’ work, but I had to,” says Liliana.
At her office, everybody was informed, via e-mail, that someone in the workplace had TB. “Of course people who worked around me all knew it was me.” TB skin tests were done on all employees; luckily no one in her workplace was found to have either latent TB infection or TB disease.
“My advice to someone who is recently diagnosed with TB is to have patience. There is hope and there is a cure, but you must be patient during your treatment.”
Liliana began treatment for TB disease, which typically takes 6 to 9 months to complete. After 3 weeks of staying home and taking her medication, she was relieved to be allowed to go back to work. It was a shock to hear 2 weeks later that her TB disease was resistant to most of the medications she was taking. Liliana was diagnosed with MDR TB, which is caused by TB bacteria that are resistant to at least isoniazid and rifampin, two of the most effective TB drugs.
Because MDR TB is much more difficult to treat, she was sent to the Texas Center for Infectious Disease (TCID) hospital in San Antonio for further evaluation. The doctors there would determine what other drugs they could give her for treatment. She did not know how long she was going to be there and was confused and anxious. “I was in denial and mad at everybody,” she shares. Although it was frightening, her husband was supportive in every respect. “The entire experience brought my husband and me closer. He was my biggest supporter, as was my family.” Luckily, part of her family lived in San Antonio, which was very helpful.
Unfortunately, the treatment Liliana took in high school for TB infection was not effective against the drug-resistant bacteria. Liliana’s doctors told her that it was possible that all the stress and exhaustion leading up to her wedding could have suppressed her natural immunity and lessened her ability to fight off the TB bacteria that were still in her body.
Because MDR TB is much more difficult to treat than regular TB, Liliana was in the hospital for 2 months. It was a hard time for Liliana. Her treatment required taking many pills and getting two painful shots every day. In addition, she was having unpleasant side effects from the drugs. Her medical team decided to give her a peripherally inserted central catheter (PICC) line, which made it easier to inject the drugs and draw blood.
After being released from the hospital, Liliana was able to return to work since she was no longer infectious. However, she still had to receive treatment at home for the next 16 months. Fortunately, the local TB control program was there to give her the help she needed. Because TB disease is so serious, and missing some doses can lead to the development of drug resistance, CDC recommends directly observed therapy (DOT) for all TB patients. This ensures that every dose is taken and documented by a health care worker. This was even more important for Liliana because she already was resistant to several of the TB medications. Liliana explained that because taking 14 pills a day was too much to take at one time, the local TB control program worked to accommodate her schedule. They broke up the regimen so she could take half her pills in the morning and the other half in the evening. “A volunteer would be at my house at 6 in the morning. Then after work I would come home, and a nurse would be waiting for me as I took my other pills,” she explains.
The side effects were challenging for Liliana as she continued working during her treatment. “I was often drowsy and tired. I would come home from a long day of work, but instead of being able to relax, I would have more medication to take,” she says.
But the TB control program workers were supportive and helped her get through it. “All the staff were friendly and always laughing and making the best of it.”
It took 1 1⁄2 years for Liliana to complete her treatment. “To this day, I still keep in contact with the TB control program workers. If I have a cough, I let them know, so I can be checked and make sure I don’t have TB again,” she says.
Liliana adds, “My advice to someone who is recently diagnosed with TB is to have patience. There is hope and there is a cure, but you must be patient during your treatment.”More TB Personal Stories
							
					
						Page last reviewed:  February 26, 2014					Content source: 	Division of Tuberculosis Elimination, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention homeTuberculosisBasic TB Factsplus iconHow TB SpreadsLatent TB Infection and TB DiseaseSigns & SymptomsTB Risk FactorsExposure to TBTB PreventionVaccinesTB & HIV CoinfectionTB and DiabetesTB TermsPersonal StoriesTesting & Diagnosisplus iconWho Should be TestedTesting for TB InfectionTesting in BCG-Vaccinated PersonsTB Screening and Testing of Health Care PersonnelTesting During PregnancyDiagnosing latent TB infection and TB diseaseTreatmentplus iconDeciding When to Treat Latent TB InfectionTreatment Regimens for Latent TB Infection (LTBI)Treatment for TB DiseaseAdverse EventsTB Treatment of Persons Living with HIVTB Treatment and PregnancyTB Treatment for ChildrenFrequently Asked QuestionsDrug-Resistant TBResearchplus iconTB Epidemiologic Studies Consortiumplus iconResearch ProjectsPublicationsTB Trials Consortiumplus iconStudy DescriptionsBackgroundBehavioral & Social Science ResearchHealth Care Settingsplus iconTB Infection Control in Health Care SettingsResources for TB Screening and Testing of Health Care Personnelplus iconFrequently Asked QuestionsTB in Specific Populationsplus iconHealth DisparitiesAsian PersonsBlack or African American PersonsHispanic or Latino PersonsChildrenPregnancyCorrectional FacilitiesPeople Experiencing HomelessnessInternational TravelersLaboratory Informationplus iconDrug Susceptibility TestingFalse-Positive Investigation ToolkitInterim Laboratory Biosafety Guidance for XDR  tuberculosis strainsModel Performance Evaluation Program (MPEP)Rapid Molecular Testing to Detect Drug-Resistant TB in the USplus iconExecutive SummaryIntroductionBackground on Tests for Molecular Detection of DRGeneral Considerations and Principles for a Molecular DR Testing ServicePossible Scenarios and Scope of Testing for a Molecular DR Testing ServiceResearch NeedsGeneral Recommendations of the Expert PanelCommunication Plan for the ReportRecommendationsReferencesPanel Members and CDC ParticipantsAppendix 1Appendix 2Appendix 3The Uses of Nucleic Acid Amplification Tests for the Diagnosis of TBplus iconGeneral ConsiderationsGeneral Recommendations of the Expert PanelRecommendations to ACET, CDC, DTBEData & Statisticsplus iconTB Incidence in the United StatesReported TB in the US, 2022 Surveillance Reportplus iconNational DataReporting Area DataRisk FactorsDemographicsTB Treatment and Case OutcomesDrug-Resistant TBMolecular SurveillanceTuberculosis in the United States, 2022 (Slide Set)Archived Surveillance Reports and Slide Sets2021 State and City ReportArchived State and City ReportsProfessional Resources & Toolsplus iconTools for Healthcare ProvidersResources for TB Programsplus iconStrengthening Civil Surgeons’ Capacity to Improve LTBI Surveillance and Outcomes Among Status AdjustersNotice of Funding Opportunity (NOFO)Program EvaluationTB Centers of ExcellenceTB Elimination AllianceTB Genotypingplus iconConventional TB GenotypingWhole Genome SequencingTB GIMSAnalytic ToolsLatent Tuberculosis Infection ResourcesPublications & Productsplus iconPatient and Public MaterialsFact SheetsGuidelinesplus iconControl & EliminationDrug-Resistant TBInfection Control & PreventionLaboratory & GenotypingTB & HIVTB in Specific PopulationsTesting & DiagnosisTreatmentVaccines & ImmunizationsArchived TB GuidelinesGuides & Toolkitsplus iconAggregate ReportsCDC TB Surveillance TrainingCore CurriculumEffective TB Interviewing for Contact InvestigationEthnographic GuidesFalse-Positive Investigation ToolkitForging Partnerships to Eliminate TuberculosisGuide to Application of GenotypingLTBI: A Guide for Primary Health Care ProvidersMantoux Tuberculin Skin Testing ProductsReport of Verified Case of Tuberculosis (RVCT)Self-Study ModulesTB Contact Investigation Interviewing Skills CourseTB eDOT ToolkitUnderstanding the TB Cohort Review ProcessNewslettersplus iconTB Notes, No. 4, 2023TB Notes, No. 3, 2023TB Notes. No. 2, 2023TB Notes. No. 1, 2023TB Notes, No. 4, 2022TB Notes, No. 3, 2022TB Notes, No. 2, 2022TB Notes, No. 1, 2022TB Notes, No. 4, 2021TB Notes, No. 3, 2021TB Notes, No. 2, 2021TB Notes, No. 1, 2021Pamphlets, Brochures, Bookletsplus iconQuestions and AnswersPatient Education SeriesTuberculosis - Get the FactsTuberculosis - The Connection between TB and HIV12-Dose Regimen for Latent TB Infection-Patient Education BrochurePostersplus iconMantoux Tuberculin Skin Test Wall ChartWorld TB DayThink TBStop TBTake on TBReports & Articlesplus iconDTBE Authored Journal ArticlesTuberculosis Laboratory Aggregate ReportsSlide Setsplus iconIntroduction to TuberculosisEpidemiology of Tuberculosis Among Non-U.S.​–Born Persons in the United States, 1993–2016Self-Study Modules on Tuberculosis, 1-5 Slide SetsThe Tuberculosis (TB) in Correctional Settingsplus iconFacilitator GuideIntroduction to TB GenotypingEpidemiology of Tuberculosis in Correctional Facilities, United States, 1993-2017Prevention and Control of Tuberculosis in Correctional and Detention FacilitiesGuidelines for Preventing the Transmission of M. TB in Health care SettingsInvestigation of Contacts of Persons with Infectious TBEpidemiology of Pediatric Tuberculosis in the United StatesTargeted Tuberculosis Testing and Treatment of Latent Tuberculosis InfectionElectronic Tools & ResourcesWeb-Based Courses & Webinarsplus iconTB 101 for Health Care WorkersContent SyndicationInfographicsplus iconSocial Media GraphicsCustomizable Take on TB Infographic with InstructionsEventsWorld TB Dayplus iconU.S. TB ChampionsHistoryFeaturesplus iconTB Risk FactorsTreating Latent TB Infection with Short-Course RegimensWorld Tuberculosis (TB) Day 2021World Tuberculosis (TB) Day 2020Linksplus iconState TB Control OfficesAbout Usplus iconMission Statement and Activitiesplus iconDTBE Strategic PlanNational TB Program ObjectivesOrganization ChartAdvisory Groupsplus iconFederal TB Task Force To receive email updates about this page, enter your email address: Email Address			What's this?				Submit


About CDC
					Contact Us
					800-232-4636
 Facebook Twitter Instagram LinkedIn Youtube Pinterest Snapchat
 CONTACT CDC
				Contact Us
							Call 800-232-4636
							Email Us
			ABOUT CDC
				About CDC
							Jobs
							Funding
			POLICIES
				Accessibility
							External Links
							Privacy
							Policies
							No Fear Act
							FOIA
							OIG
							Nondiscrimination
							Vulnerability Disclosure Policy
			CONNECT WITH US
				Facebook
								Twitter
								Instagram
								LinkedIn
							Youtube
								Pinterest
								Snapchat
								Email
			LANGUAGES
				Español
							繁體中文
							Tiếng Việt
							한국어
							Tagalog
							Русский
							العربية
							Kreyòl Ayisyen
							Français
							Polski
							Português
							Italiano
							Deutsch
							日本語
							فارسی
							English


U.S. Department of Health & Human Services
			Accessibility
			External Links
			Privacy
			Policies
			No Fear Act
			FOIA
			Nondiscrimination
			OIG
			Vulnerability Disclosure Policy
			USA.gov


Exit Notification / Disclaimer Policy Close
 Links with this icon  indicate that you are leaving the CDC website. The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
				Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
				You will be subject to the destination website's privacy policy when you follow the link.
				CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website. Website Disclaimers
 Cancel Continue